Global Comparator Drug Sourcing Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Comparator Drug Sourcing Market Insights, Forecast to 2034
Comparator drug sourcing is a sourcing approach whereby the comparator product is accepted within a single country and used in a clinical trial inside the same country. The product evades charges on import and export and regulations, which is considered to speed up the clinical trial supply chain and is cost-effective.
Market Analysis and InsightsGlobal Comparator Drug Sourcing Market
Global Comparator Drug Sourcing market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Comparator Drug Sourcing industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
Globally, Comparator Drug Sourcing key companies include AmerisourceBergen Corporation, Avantor, Inc., Catalent, Clinical Services International (CSI), Clinigen Clinical Supplies Management, Intertek Group, MCKESSON CORPORATION, Myonex and PHARMA’S ALMANAC, etc. AmerisourceBergen Corporation, Avantor, Inc., Catalent are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Comparator Drug Sourcing were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Comparator Drug Sourcing market and estimated to attract more attentions from industry insiders and investors.
Comparator Drug Sourcing can be divided into Local Sourcing, Central Sourcing and Market Sourcing,, etc. Local Sourcing is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Comparator Drug Sourcing is widely used in various fields, such as Drug Producers/Manufacturers, CMO, Academic and Research Institute and Others, etc. Drug Producers/Manufacturers provides greatest supports to the Comparator Drug Sourcing industry development. In 2022, global % revenue of Comparator Drug Sourcing went into Drug Producers/Manufacturers filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Comparator Drug Sourcing market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Comparator Drug Sourcing market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
AmerisourceBergen Corporation
Avantor, Inc.
Catalent
Clinical Services International (CSI)
Clinigen Clinical Supplies Management
Intertek Group
MCKESSON CORPORATION
Myonex
PHARMA’S ALMANAC
Sharp Services, LLC
Thermo Fisher Scientific
TransCelerate BioPharma Inc.
Segment by Type
Local Sourcing
Central Sourcing
Market Sourcing
Drug Producers/Manufacturers
CMO
Academic and Research Institute
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Comparator Drug Sourcing introduction, etc. Comparator Drug Sourcing Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Comparator Drug Sourcing
Chapter 13Methodology and Data Sources adopted by MRAResearch
Market Analysis and InsightsGlobal Comparator Drug Sourcing Market
Global Comparator Drug Sourcing market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Comparator Drug Sourcing industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
Globally, Comparator Drug Sourcing key companies include AmerisourceBergen Corporation, Avantor, Inc., Catalent, Clinical Services International (CSI), Clinigen Clinical Supplies Management, Intertek Group, MCKESSON CORPORATION, Myonex and PHARMA’S ALMANAC, etc. AmerisourceBergen Corporation, Avantor, Inc., Catalent are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Comparator Drug Sourcing were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Comparator Drug Sourcing market and estimated to attract more attentions from industry insiders and investors.
Comparator Drug Sourcing can be divided into Local Sourcing, Central Sourcing and Market Sourcing,, etc. Local Sourcing is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Comparator Drug Sourcing is widely used in various fields, such as Drug Producers/Manufacturers, CMO, Academic and Research Institute and Others, etc. Drug Producers/Manufacturers provides greatest supports to the Comparator Drug Sourcing industry development. In 2022, global % revenue of Comparator Drug Sourcing went into Drug Producers/Manufacturers filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Comparator Drug Sourcing market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Comparator Drug Sourcing market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
AmerisourceBergen Corporation
Avantor, Inc.
Catalent
Clinical Services International (CSI)
Clinigen Clinical Supplies Management
Intertek Group
MCKESSON CORPORATION
Myonex
PHARMA’S ALMANAC
Sharp Services, LLC
Thermo Fisher Scientific
TransCelerate BioPharma Inc.
Segment by Type
Local Sourcing
Central Sourcing
Market Sourcing
Segment by Application
Drug Producers/Manufacturers
CMO
Academic and Research Institute
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Comparator Drug Sourcing introduction, etc. Comparator Drug Sourcing Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Comparator Drug Sourcing
Chapter 13Methodology and Data Sources adopted by MRAResearch